https://www.selleckchem.com/products/U0126.html
Posteriors will be summarised using median values as point estimates and percentile-based 95% credibility intervals. Probabilities of any benefit/harm, clinically important benefit/harm and clinically unimportant differences will be presented for all outcomes. The results of this secondary, pre-planned Bayesian analysis will complement the primary frequentist analysis of the AID-ICU trial and facilitate a nuanced and probabilistic interpretation of the trial results. The results of this secondary, pre-planned Bayesian analysis will comple
Curtir
Comentario
Compartilhar
